CN Stock MarketDetailed Quotes

688373 Shanghai Micurx Pharmaceutical

Watchlist
  • 5.04
  • -0.17-3.26%
Market Closed Nov 15 15:00 CST
3.30BMarket Cap-7058P/E (TTM)

Shanghai Micurx Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shanghai Micurx Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 25, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
36.82M
--
+40.75%
EPS
--
-0.14
--
--
Analyst Rating
Strong Buy

Nov 16, 2024

Shanghai Micurx Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 251.000M--
--2024/FY-- / 156.000M--
Mar 28, 20242023/FY90.776M / 103.000M--
Mar 25, 20232022/FY48.207M / 50.000M--
--2021/FY7.660M / ----
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 251.000M--
--2024/FY-- / 156.000M--
Mar 28, 20242023/FY90.776M / 103.000M--
Mar 25, 20232022/FY48.207M / 50.000M--
--2021/FY7.660M / ----

Unlock Free Earnings Estimates

Shanghai Micurx Pharmaceutical Earnings Reports

  • Shanghai Mengke Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024

    Oct 24 12:00 ET

  • Shanghai Mengke Pharmaceutical Co., Ltd. 2024 Semi-Annual Report

    Aug 28 12:00 ET

  • Summary of the 2024 semi-annual report of Shanghai Mengke Pharmaceutical Co., Ltd.

    Aug 28 12:00 ET

  • Shanghai Mengke Pharmaceutical Co., Ltd. Report for the first quarter of 2024

    Apr 25 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 16, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data